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Introduction
Hyperkalemia is a common side-effect of heart failure treatment. 
The prevalence of hyperkalemia in the general population is unkno-
wn but reported to be 1-10% in hospitalized patients.
1-4) The most 
common predisposing factors are impaired kidney function and 
drugs such as angiotensin-converting enzyme inhibitors, angioten-
sin-II receptor antagonists, and aldosterone antagonists.
1)5)6) Cardi-
ac manifestations of hyperkalemia are sometimes lethal with vari-
ous presentations. The common electrocardiographic changes in 
patients with hyperkalemia include a tented T wave, PR interval pro-
longation, QRS widening, ventricular fibrillation, and asystole. It has 
been suggested that hyperkalemia may be associated with tran-
sient sinus conversion of atrial fibrillation (AF), and, indeed, we report 
here a case of hyperkalemia resulting in sinus conversion from 
permanent AF. 
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Case
A 74-year-old woman was admitted to the hospital for diarrhea 
and epigastric pain. She had a history of hypertension, diabetes mel-
litus, chronic kidney disease, dilated cardiomyopathy, and perma-
nent AF for 5 years (Fig. 1). Echocardiography performed 3 months 
before admission revealed severe global left ventricular hypokine-
sia (ejection fraction=19% by Simpson’s method) and an enlarged 
left atrium (left atrial volume index=40 mL/m
2). Her medications in-
cluded digoxin (0.125 mg daily), warfarin (2 mg daily), ramipril (10 
mg daily), furosemide (40 mg daily), spinolactone (25 mg daily), 
and carvedilol (25 mg daily). 
On examination, her heart rate was 41 bpm, and blood pressure 
was 110/70 mm Hg. Heart sounds were regular, and there were no 
murmurs or thrills. An electrocardiogram (ECG) revealed junctional 
rhythm at a rate of 35 bpm and a QRS duration of 136 msec (Fig. 2). 
Admission laboratory results showed severe hyperkalemia (serum 
potassium 8.3 mEq/L), high blood urea nitrogen (62.4 mg/dL), cre-
atinine of 4.0 mg/dL, glucose of 248 mg/dL, and low sodium (131 
mM) and hemoglobin (7.2 g/dL) levels. Arterial blood gas analysis 
on room air showed a pH of 7.400, pCO2 of 41.6 mm Hg, pO2 of 102.8 
mm Hg, and HCO3
- of 26.0 mmol/L. 
The patient was immediately treated with intravenous calcium ch-
loride, followed by intravenous glucose/insulin and a sodium bi-
carbonate infusion. On hospital day 2, the serum potassium level 
was 5.3 mEq/L and the ECG showed sinus bradycardia at a rate of 
53 bpm with an 80 ms QRS duration (Fig. 3). On hospital day 3, the 
ECG revealed a normal sinus rhythm at a rate of 67 bpm, and the se-
rum potassium level was within normal limits (4.3 mEq/L). The pa-66  Hyperkalemia Induced Sinus Conversion in Patients With Atrial Fibrillation
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tient was discharged 6 days after admission, and the ECG at dis-
charge showed normal sinus rhythm at a rate of 65 bpm with occa-
sional premature ventricular complexes. At the 10 day and 1 month 
follow-ups, the ECG at an outpatient clinic had returned to AF and 
serum potassium levels were within the normal range.
Discussion
Hyperkalemia causes various ECG changes. In mild to moderate hy-
perkalemia, depression of conduction between cardiac myocytes re-
sults in prolongation of the PR and QRS intervals as potassium levels 
increase. Severe hyperkalemia induces suppression of sinoatrial and 
atrioventricular conduction, resulting in sinoatrial and atrioventric-
ular blocks, escape beats, and escape rhythms.
7) At extremely high 
serum potassium levels, the QRS complex is markedly widened and 
fused with the T wave, creating a sine-wave appearance on ECG.
8) 
Interestingly, previous reports have documented unusual cardiac 
manifestations related to hyperkalemia, including pacemaker cap-
ture and sensing failure,
9)10) loss of the delta wave in patients with 
Wolff-Parkinson-White syndrome,
7) and transient sinus conversion 
                      Fig. 1. The electrocardiogram performed prior to admission was atrial fibrillation at a rate of 92 bpm.
Fig. 2.  The electrocardiogram performed on admission revealed Junctional bradycardia at a rate of 35 bpm and QRS duration of 136 milliseconds (K
+ : 8.3 mEq/L).
Fig. 3.  The electrocardiogram performed on hospital day 2 showed sinus bradycardia at a rate of 53 bpm and QRS duration of 80 milliseconds (K
+ : 5.3 mEq/L).67 Ji Hyun Yoon, et al.
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of permanent AF during treatment for hyperkalemia.
11-13) However, 
the mechanisms in these cases were not clearly defined. 
In this case, the ECG on admission showed junctional bradycardia 
with a widened QRS complex. The ECG recovered to sinus bradycar-
dia after the shift of potassium from the intracellular to extracellu-
lar space induced by intravenous glucose/insulin and sodium bicar-
bonate. Transmembrane permeabililty increases with the develop-
ment of hyperkalemia and causes potassium influx into cells,
5) which, 
in turn, causes decreased and shortened cellular action potentials by 
inactivating the sodium channel
5)8)14) and delayed conduction be-
tween myocytes. As a result, hyperkalemia decreases excitability of 
atrial tissue, suppressing an irritable atrial ectopic focus and re-
entrant circuit.
11) The ECG findings of junctional bradycardia with 
widening of the QRS complex on admission are explained by these 
mechanisms. Because the sinus node is less sensitive to high potas-
sium level than atrial tissue, hyperkalemia suppresses sinus nodal 
function to a lesser degree than atrial tissue conduction.
11) Therefore, 
sinus rhythm may recover earlier than AF activity in patients with 
permanent AF during treatment for hyperkalemia.
The latter phenomena have some similarities with pharmacolog-
ical characteristics of amiodarone, which is the most effective anti-
arrhythmic drug available for maintaining sinus rhythm in patients 
with AF. Oral amiodarone results in pharmacological cardioversion 
of AF in up to 40% of patients.
15) Amiodarone blocks potassium ch-
annels and inactivates sodium channels, thereby prolonging repo-
larization, action potential duration, and refractory period.
16-19) Be-
cause the relative potency of these effects is greater in the atrium,
20) 
amiodarone suppresses atrial ectopic activity and maintains sinus 
rhythm. During treatment for hyperkalemia, intracellular potassium 
depletion that occurs by the extracellular shift in potassium pro-
longs repolarization, action potential duration, and refractory period. 
These mechanisms are similar to amiodarone-induced sinus con-
version by blocking the inward potassium channel. 
The maintenance duration of sinus rhythm that occurs during tr-
eatment for hyperkalemia remains undetermined and appears to 
vary according to clinical course. In a case report of hyperkalemia-
induced sinus conversion, sinus rhythm was maintained for 3 mon-
ths after normalization of serum potassium level
11) and another case 
report of permanent AF with severe hyperkalemia described tran-
sient sinus conversion of only 16 minutes duration.
12) In our patient, 
the ECG returned to AF after 10 days of normal serum potassium 
levels. Therefore, sinus rhythm during the recovery phase of hyper-
kalemia seems to eventually revert to AF within several weeks to 
months, so it is necessary to maintain proper treatment for AF.
In conclusion, other than well-known ECG features of hyperka-
lemia, restoration of sinus rhythm in patients with AF may occur dur-
ing treatment for hyperkalemia, so it is important to maintain treat-
ment for AF even after sinus conversion.
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